Request a Proposal
Welcome to Rapport, containing tips, truths, news and views, blogs, tweets, articles and films covering a range of topics currently affecting Research Partnership and the pharma market research world
  • Posted by Liza Pliss, Will Simpson and Emilie Braund
  • June 26, 2020
  • Webinars

Digital #marcomms: How to evaluate and optimise marketing activities impacted by COVID-19

Digital #marcomms: How to evaluate and optimise marketing activities impacted by COVID-19

Our experts consider the impact the pandemic has and will continue to have on marketing in global healthcare and look at the continued shift towards digital communications as a means to engage physicians and patients.  

read more »

  • Posted by Emily Hoffman
  • May 28, 2020
  • Events

Intellus Worldwide Summit 2020

Intellus Worldwide Summit 2020

We are delighted to be exhibiting at the virtual 2020 Intellus Worldwide Summit from 9th-10th June. Representing Research Partnership at the event will be Emily Hoffman, Associate Director. 

read more »

  • Posted by Mariel Metcalfe
  • May 26, 2020
  • News

Research Partnership publishes new patient syndicated reports - Living with Severe & Eosinophilic Asthma US, Japan, 2EU

Research Partnership publishes new patient syndicated reports - Living with Severe & Eosinophilic Asthma US, Japan, 2EU

Living with severe & eosinophilic asthma is a new syndicated report which offers valuable insights into patient attitudes and behaviour. The EU study was conducted amongst 118 patients with diagnosis and/or confirmed characteristics of severe asthma (SA) or eosinophilic asthma (EA) in France and Germany. The US study was conducted with 105 SA and EA patients. For both studies the methodologies consisted of 30-minute quantitative online interviews and a small sample of 30-minute qualitative add-on telephone interviews. The Japan report will also be available to purchase over the coming weeks. 

read more »

How we conducted rare disease patient research during the COVID-19 lockdown in China

How we conducted rare disease patient research during the COVID-19 lockdown in China

Our client needed to conduct a small number of qualitative interviews in China with patients diagnosed with a rare condition which affects children and young adults. The results of the survey were time critical as they were needed to inform a protocol being published in 30 working days. We faced two key challenges, firstly to find, screen and recruit diagnosed patients with a prevalence of 0.9 per 100,000 and secondly to achieve this during the restrictions of the COVID-19 lockdown in 2020.
 

read more »

  • Posted by Danielle Christmas
  • May 26, 2020
  • Blogs

The impact of COVID-19 on rare disease patients in the EU

 The impact of COVID-19 on rare disease patients in the EU

We’re living in challenging times. Everyone is struggling in some way or another as a result of the ongoing lockdowns and current social distancing measures that are in place, aimed at shielding mankind from the ‘invisible enemy’ that is COVID-19. Over the last few months, as we’ve all been muddling through, I have often found myself thinking about those people who are living with a rare disease, and the additional impact that the pandemic must be having on their lives.

read more »